<SEC-DOCUMENT>0001140361-22-032659.txt : 20220908
<SEC-HEADER>0001140361-22-032659.hdr.sgml : 20220908
<ACCEPTANCE-DATETIME>20220908060117
ACCESSION NUMBER:		0001140361-22-032659
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20220908
FILED AS OF DATE:		20220908
DATE AS OF CHANGE:		20220908

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IPERIONX Ltd
		CENTRAL INDEX KEY:			0001898601
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS METAL ORES [1090]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41338
		FILM NUMBER:		221232453

	BUSINESS ADDRESS:	
		STREET 1:		129 W TRADE STREET
		STREET 2:		SUITE 1405
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28202
		BUSINESS PHONE:		7045783217

	MAIL ADDRESS:	
		STREET 1:		129 W TRADE STREET
		STREET 2:		SUITE 1405
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Hyperion Metals Ltd
		DATE OF NAME CHANGE:	20211210
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>brhc10041720_6k.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM 6-K</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER</div>
      <div style="text-align: center; font-weight: bold;">Pursuant to Rule 13a-16 or 15d-16 of the</div>
      <div style="text-align: center; font-weight: bold;">Securities Exchange Act of 1934</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">Date: September 8, 2022</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Commission File Number:</font><font style="font-size: 10pt;">&#160;<font style="font-weight: bold;">001-41338</font></font></div>
      <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt;"><font style="font-weight: bold;"> <br>
          </font></font></div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-align: center; font-size: 24pt; font-weight: bold;">IperionX Limited</div>
      <div style="text-align: center; font-weight: bold;">(Translation of registrant&#8217;s name into English)</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">129 W Trade Street, Suite 1405</div>
      <div style="text-align: center; font-weight: bold;">Charlotte, North Carolina</div>
      <div style="text-align: center; font-weight: bold;">(Address of principal executive offices)</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-indent: 36pt;"> <br>
      </div>
      <div style="text-indent: 36pt;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
      <div><br>
      </div>
      <div style="text-indent: 108pt; font-size: 14pt;"><font style="font-size: 10pt;">Form 20-F X&#160; &#160; Form 40-F &#9744;</font></div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; font-size: 14pt;"><font style="font-size: 10pt;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): &#9744;</font></div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; font-size: 14pt;"><font style="font-size: 10pt;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): &#9744;</font></div>
      <div><br>
      </div>
      <div>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">EXHIBIT INDEX</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div>The following exhibits are filed as part of this Form 6-K:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zb13bdeea280e4cbba52f9f51528712ed" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Exhibit</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Description</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 9%; vertical-align: top;">
              <div><a href="brhc10041720_ex99-1.htm">99.1</a></div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 90%; vertical-align: top;">
              <div>Press Release issued by IperionX Limited</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
      <div style="text-align: center;"> <br>
      </div>
      <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z5f1dbf74581d4b5b81911c2578813995" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div>IPERIONX LIMITED</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div>(registrant)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">
              <div>Date: September 8, 2022</div>
            </td>
            <td style="width: 50%; vertical-align: bottom;">
              <div>By:&#160;<u>/s/ Gregory Swan</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div>Name: Gregory Swan</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div>Title:&#160;&#160; Chief Financial Officer</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>&#160;
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>brhc10041720_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div>
        <div style="text-align: right; color: rgb(0, 0, 0); font-weight: bold;">Exhibit 99.1</div>
        <div>&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zd32077e06c314f3ba607c8b4694083f9">

              <tr>
                <td style="width: 50%;">
                  <div><img src="image01.jpg"></div>
                </td>
                <td style="width: 50%; color: rgb(0, 0, 0);">
                  <div style="text-align: right;"><font style="font-weight: bold;">PRESS RELEASE </font>| NASDAQ: IPX | ASX: IPX</div>
                </td>
              </tr>

          </table>
        </div>
        <div><br>
        </div>
        <div style="text-align: right; color: rgb(0, 0, 0); font-style: italic;">September 8, 2022</div>
        <div>&#160;<br>
        </div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">Not for release to US wire services or distribution in the United States</div>
        <div>&#160;</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">IPERIONX COMPLETES $24M PLACEMENT</div>
        <div>&#160;</div>
        <div style="text-align: justify; color: rgb(110, 113, 112);"><font style="font-weight: bold; color: rgb(0, 0, 0);">IperionX Limited (&#8220;IperionX&#8221; or &#8220;Company&#8221;) (NASDAQ: IPX, ASX: IPX) </font><font style="color: rgb(0, 0, 0);">is pleased to announce
            that it has received commitments to place 30 million shares at an issue price of A$0.80 per share to institutional, sophisticated and professional investors to raise gross proceeds of A$24 million before costs (&#8220;Placement&#8221;).</font></div>
        <div style="color: rgb(0, 0, 0);">&#160;</div>
        <div style="text-align: justify; color: rgb(0, 0, 0);">The Placement was led by cornerstone investors B. Riley Principal Investments, a wholly owned subsidiary of B. Riley Financial, Inc., and Fidelity International Ltd (&#8220;FIL&#8221;), a global asset
          manager. The Company is also pleased that its largest shareholder, Fidelity Management &amp; Research Company (&#8220;FMR&#8221;), has agreed to subscribe for shares to maintain its pro-rata position, confirming its continued support for the Company. The
          Placement also included a dedicated sustainability focused investor based in the United States.</div>
        <div style="color: rgb(0, 0, 0);">&#160;</div>
        <div style="text-align: justify; color: rgb(0, 0, 0);">Mr. Todd Hannigan, Executive Chairman of IperionX, also plans to participate in the Placement by subscribing for a total of 1,875,000 shares, subject to Shareholder approval.</div>
        <div style="color: rgb(0, 0, 0);">&#160;</div>
        <div style="text-align: justify; color: rgb(0, 0, 0);">Proceeds from the Placement will be used to continue the scale-up and commercialization of IperionX&#8217;s titanium metal technologies, including capital upgrades to the existing titanium pilot
          facility, deposits on long lead time equipment for a proposed titanium demonstration facility, and continued research and development activities. IperionX will also continue development of the Company&#8217;s critical minerals project located in
          Tennessee, including a pre-feasibility study, permitting, and continued exploration.</div>
        <div style="color: rgb(0, 0, 0);">&#160;</div>
        <div style="text-align: justify; color: rgb(0, 0, 0);">Ord Minnett Limited acted as Lead Manager to the Placement and B. Riley Securities, Inc. acted as financial advisor. The issue price of A$0.80 per share represents a 6.4% discount to the last
          closing price of A$0.855. As a result of the planned participation by a Director, the Placement will be completed in two tranches as follows:</div>
        <div style="text-align: justify; margin-right: 5.95pt; margin-left: 54pt; color: rgb(110, 113, 112);"> <font style="color: rgb(0, 0, 0);"><br>
          </font></div>
        <table cellspacing="0" cellpadding="0" id="z15c3190ad61f4d7fa478bac7d9863ed2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">
                <div>(a)</div>
              </td>
              <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                <div style="text-align: justify;">28,125,000 shares will be issued on or about September 14, 2022 under Listing Rules 7.1 (14,064,951 shares) and 7.1A (14,060,049 shares); and</div>
              </td>
            </tr>

        </table>
        <div> <font style="color: rgb(0, 0, 0);"><br>
          </font></div>
        <table cellspacing="0" cellpadding="0" id="z98c1a2a46247451293f913c323641dc3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">
                <div>(b)</div>
              </td>
              <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                <div style="text-align: justify;">1,875,000 shares will be issued to Mr. Todd Hannigan following shareholder approval. A notice of meeting will be sent to shareholders shortly to approve Mr. Hannigan&#8217;s participation.</div>
              </td>
            </tr>

        </table>
        <div style="color: rgb(0, 0, 0);">&#160;</div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;">This press release is not an offer or sale of the securities in the United States or in any other jurisdiction where such offer or sale is prohibited, and such securities may
          not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act of 1933, as amended.</div>
        <div style="color: rgb(0, 0, 0);">&#160;</div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">About IperionX</div>
        <div style="color: rgb(0, 0, 0);">&#160;</div>
        <div style="text-align: justify; color: rgb(0, 0, 0);">IperionX&#8217;s mission is to be the leading developer of low carbon, sustainable, critical material supply chains focused on advanced industries including space, aerospace, electric vehicles and 3D
          printing. IperionX&#8217;s breakthrough titanium technologies have the potential to produce titanium products which are sustainable, 100% recyclable, low carbon intensity and at product qualities which exceed current industry standards. The Company
          also holds a 100% interest in the Titan Project, located in Tennessee, U.S., a very large titanium resource in North America which is also rich in rare earth minerals.</div>
        <div style="color: rgb(0, 0, 0);">&#160;</div>
        <div style="text-align: justify; color: rgb(0, 0, 0);">This announcement has been authorized for release by the CEO and Managing Director. </div>
        <div style="text-align: justify; color: rgb(0, 0, 0);"> <br>
        </div>
        <div style="text-align: justify; color: rgb(0, 0, 0);">For further information and enquiries please contact:</div>
        <div style="color: rgb(0, 0, 0);">&#160;</div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">info@iperionx.com</div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">+1 980 237 8900</div>
        <div style="color: rgb(0, 0, 0);">&#160;</div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">www.iperionx.com</div>
        <div><br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zdce94653a979414d99e984b09391e3bc">

              <tr>
                <td style="width: 10%;" rowspan="2" colspan="1">
                  <div style="text-align: left;">&#160;<img src="image02.jpg"></div>
                </td>
                <td style="width: 1%;" colspan="1">&#160;</td>
                <td style="width: 32%;">
                  <div><font style="color: rgb(0, 0, 0); font-weight: bold;">Corporate Office</font></div>
                </td>
                <td style="width: 1%;" colspan="1">&#160;</td>
                <td style="width: 26%;">
                  <div><font style="color: rgb(0, 0, 0); font-weight: bold;">Tennessee Office</font></div>
                </td>
                <td style="width: 1%;" colspan="1">&#160;</td>
                <td style="width: 29%;">
                  <div><font style="font-weight: bold; color: rgb(0, 0, 0);">Salt Lake City Office</font></div>
                </td>
              </tr>
              <tr>
                <td style="width: 1%;" colspan="1">&#160;</td>
                <td nowrap="nowrap" style="width: 32%;">
                  <div><font style="color: rgb(0, 0, 0);">129 W Trade St, Suite 1405 Charlotte, NC 28202</font></div>
                </td>
                <td nowrap="nowrap" style="width: 1%;" colspan="1">&#160;</td>
                <td nowrap="nowrap" style="width: 26%;">
                  <div>279 West Main St, Camden, TN 38320</div>
                </td>
                <td nowrap="nowrap" style="width: 1%;" colspan="1">&#160;</td>
                <td nowrap="nowrap" style="width: 29%;">
                  <div>1782 W 2300 S, West Valley City, UT 84119</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: right;" id="DSPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">1</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
      </div>
      <font style="color: rgb(0, 0, 0); font-weight: bold;">Forward Looking Statements</font>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">Information included in this release constitutes forward-looking statements. Often, but not always, forward looking statements can generally be identified by the use of forward-looking words such
        as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221;, &#8220;estimate&#8221;, &#8220;anticipate&#8221;, &#8220;continue&#8221;, and &#8220;guidance&#8221;, or other similar words and may include, without limitation, statements regarding plans, strategies and objectives of management, anticipated
        production or construction commencement dates and expected costs or production outputs.</div>
      <div style="color: rgb(0, 0, 0);">&#160;</div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">Forward looking statements inherently involve known and unknown risks, uncertainties and other factors that may cause the Company&#8217;s actual results, performance, and achievements to differ
        materially from any future results, performance, or achievements. Relevant factors may include, but are not limited to, changes in commodity prices, foreign exchange fluctuations and general economic conditions, increased costs and demand for
        production inputs, the speculative nature of exploration and project development, including the risks of obtaining necessary licenses and permits and diminishing quantities or grades of reserves, the Company&#8217;s ability to comply with the relevant
        contractual terms to access the technologies, commercially scale its closed-loop titanium production processes, or protect its intellectual property rights, political and social risks, changes to the regulatory framework within which the Company
        operates or may in the future operate, environmental conditions including extreme weather conditions, recruitment and retention of personnel, industrial relations issues and litigation.</div>
      <div style="color: rgb(0, 0, 0);">&#160;</div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">Forward looking statements are based on the Company and its management&#8217;s good faith assumptions relating to the financial, market, regulatory and other relevant environments that will exist and
        affect the Company&#8217;s business and operations in the future. The Company does not give any assurance that the assumptions on which forward looking statements are based will prove to be correct, or that the Company&#8217;s business or operations will not
        be affected in any material manner by these or other factors not foreseen or foreseeable by the Company or management or beyond the Company&#8217;s control.</div>
      <div style="color: rgb(0, 0, 0);">&#160;</div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">Although the Company attempts and has attempted to identify factors that would cause actual actions, events or results to differ materially from those disclosed in forward looking statements,
        there may be other factors that could cause actual results, performance, achievements, or events not to be as anticipated, estimated or intended, and many events are beyond the reasonable control of the Company. Accordingly, readers are cautioned
        not to place undue reliance on forward looking statements. Forward looking statements in these materials speak only at the date of issue. Subject to any continuing obligations under applicable law or any relevant stock exchange listing rules, in
        providing this information the Company does not undertake any obligation to publicly update or revise any of the forward-looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.</div>
      <div style="color: rgb(0, 0, 0);">&#160;</div>
      <div><br>
      </div>
      <div style="text-align: right;"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  . )\# 2(  A$! Q$!_\0
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4WNNGD]7S?$;M.<7['^OZ_JVQ_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image02.jpg
<TEXT>
begin 644 image02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  V #X# 2(  A$! Q$!_\0
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MDK!^]N</-U [+6M4Y?DD7/ZQ7CR]HW>GJ]_Z^0ZV+=N2#OY@1D8/(KG]6T;
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1K+%1J.3OWOJ%:$53<4M#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
